Related Experiment Video
Updated: Aug 4, 2025
05:39
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
Published on: November 30, 2021
3.7K
Pediatric immune-mediated necrotizing myopathy.
Chen-Hua Wang1,2, Wen-Chen Liang2,3,4
1Department of Pediatrics, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan.
Frontiers in Neurology
|April 6, 2023
Summary
Pediatric immune-mediated necrotizing myopathy (IMNM) causes severe weakness and is hard to treat with steroids alone. Early diagnosis is key, as it mimics inherited myopathies, requiring increased awareness.
Area of Science:
- Pediatric Rheumatology
- Neuromuscular Disorders
- Autoimmune Diseases
Background:
- Immune-mediated necrotizing myopathy (IMNM) is an autoimmune condition affecting muscles.
- Most adult IMNM cases involve autoantibodies against HMGCR or SRP.
- Pediatric IMNM is rare, presenting unique diagnostic and therapeutic challenges.
Purpose of the Study:
- To review current evidence on pediatric immune-mediated necrotizing myopathy.
- To focus on epidemiology, clinical features, diagnosis, and treatment of IMNM in children.
Main Methods:
- Mini-review of existing literature on pediatric IMNM.
- Analysis of epidemiological data, clinical presentations, diagnostic criteria, and treatment outcomes.
Main Results:
- Pediatric IMNM frequently presents with severe muscle weakness.
- Corticosteroids alone are often insufficient for effective treatment.
- Delayed diagnosis is common due to similarities with inherited myopathies.
Conclusions:
- Increased awareness of pediatric IMNM is crucial for timely diagnosis.
- Prompt diagnosis and tailored treatment strategies are essential for managing severe pediatric IMNM.
- Further research into effective therapies for pediatric IMNM is warranted.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K
01:15Myasthenia Gravis: Diagnostic Tests
1.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.1K
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K